Founder Details

Jhumona Mullick
jhumona.emarketer@gmail.com

About the startup

Neuroshade

Neuroshade Limited is a pioneering organization dedicated to supporting children with neurodevelopmental disorders (NDD) and their families. Our mission is to provide comprehensive educational, therapeutic, and vocational services to empower children with special needs and integrate them into mainstream society. We offer a one-stop service hub with special education, occupational therapy, speech and language therapy, physiotherapy, psychotherapy, hydrotherapy, sensory integration therapy, and vocational training. Our special school prepares children for mainstream education, while our early intervention programs address developmental challenges at a young age. Neuroshade also supports parents and caregivers by providing counseling, training, and resources, ensuring they have the necessary knowledge and tools to support their children. Our technology-driven approach connects families with specialists, offering teleconsultations and digital resources for accessibility. With over 5000 families served locally and globally, 40+ children integrated into mainstream schools, and 300+ children receiving ongoing therapy, Neuroshade is making a significant social impact. Committed to inclusivity, empowerment, and innovation, we strive to build a society where children with special needs receive equal opportunities, respect, and the necessary support to lead fulfilling lives.

Startup Origin:
Dhaka

Send message to the founder

Please reach out to the founder of the startup if you’re interested in investing, exploring a collaboration, or connecting for any other commercial opportunity.

Scale your startup. Apply for DEIED Compliance Grant

We are currently accepting applications from the founders who have graduated the early-stage program from Accelerating Bangladesh. If that sounds like you, apply now using the link below:

Applications Closed

Thank you for your interest in Accelerating Bangladesh! Leave your email to get notified about future cohorts.